Optometry Times
Outlet metrics
Global
#570520
United States
#281824
Health/Health
#5155
Articles
-
2 days ago |
optometrytimes.com | Jordana Joy
The recent 2024 Impact Report released by VSP Vision highlights an increase in the percentage of frames made from sustainable, recycled, and biobased materials by the company. VSP has a goal of producing 50% of its eyewear frames from sustainable materials by 2025, and has documented a current percentage of 53%, according to a news release.
-
3 days ago |
optometrytimes.com | Jordana Joy
A year after its launch, CooperVision’s Generation Sight initiative is expanding its reach into additional community health centers to help bridge disparities in myopia management access.1 The expansion includes health centers in the greater Boston area and Rhode Island to reach more underresourced children in the US, according to a news release.
-
3 days ago |
optometrytimes.com | Lynda Charters
Stuart Therapeutics, Inc. announced the initial results of its phase 3 clinical trial evaluating ST-100 (vezocolmitide) ophthalmic solution for treating dry eye disease. The topline results enumerated in the company’s press release are as follows:The results highlight ST-100's potential for fast-acting healing of ocular surface damage caused by dry eye disease. The therapeutic effects were observed rapidly, with relief apparent within 2 to 4 days of treatment for both signs and symptoms.
-
4 days ago |
optometrytimes.com | Emily Kaiser Maharjan
As of this morning, the Vision Council and Rx have announced a strategic move for the Vision Expo series: Instead of hosting two annual events, Vision Expo East and Vision Expo West, there will be one Vision Expo held in Q1 of each year with the location to rotate around major US cities, starting with Orlando, Florida, in March of 2026. Following the flagship Vision Expo in 2026 in Orlando, the meeting will move to Las Vegas in 2027, New York City in 2028, and an unannounced location for 2029.
-
4 days ago |
optometrytimes.com | Jordana Joy
Alcon’s Clareon Panoptix Pro intraocular lens (IOL) has been approved for cataract patients in Canada.1 The IOL utilizes the company’s proprietary ENLIGHTEN NXT Optical technology, which delivers the lowest light scatter and highest reported light utilization of any trifocal IOL, according to a news release.
Optometry Times journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
https://optometrytimes.com/Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →